Skip to content
Trial Eligibility
Menu

Impact of Smell Testing on Health Outcomes

NCT07222891

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Smell dysfunction is frequent yet neglected. The sense of smell plays a crucial role in signaling disease, safety, and overall quality of life. However, the significance of a functional sense of smell in terms of health and well-being is often overlooked until one experiences a loss of smell due to injury or disease. Research demonstrates that individuals are often not self-aware of their smell dysfunction (i.e. they do not spontaneously report smell dysfunction as a symptom), especially if the changes are gradual, as in normal aging.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Olfactory Dysfunction
  • Wellbeing

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
7 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
Monell Chemical Senses Center
Last updated on ClinicalTrials.gov
October 6, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Pennsylvania · 1

  • Monell Chemical Senses Center · Philadelphia, PA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.